Krystal Biotech to Present at Upcoming Investor Conferences
June 05 2023 - 7:00AM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a
biotechnology company focused on developing and commercializing
genetic medicines for patients with rare diseases, announced today
that the Company will participate in the following upcoming
investor conferences:
- William Blair 43rd Annual Growth Stock Conference: Krish S.
Krishnan, Chairman and Chief Executive Officer, will present at
10:40 AM CT and host investor meetings on June 6, 2023 in Chicago,
IL.
- Goldman Sachs 44th Annual Global Healthcare Conference: Krish
S. Krishnan, Chairman and Chief Executive Officer, will present at
8:00 AM PT and host investor meetings on June 13, 2023 in Dana
Point, CA.
A live webcast of the presentations can be accessed on the
Investors section of the Company’s website and an archived replay
of each webcast will be available for approximately 30 days
following the presentation.
About Krystal Biotech, Inc.Krystal Biotech,
Inc. (NASDAQ: KRYS) is a fully integrated R&D and
commercial biotechnology company focused on genetic medicines for
patients with rare diseases. The Company has in-house GMP
manufacturing and a wide-ranging pipeline that is powered by its
proprietary, redosable HSV-1 gene delivery platform. VYJUVEKTM
is the Company’s first commercial product and is the first-ever
redosable gene therapy and the only medicine approved by the FDA
for the treatment of dystrophic epidermolysis bullosa. For
more information, please visit http://www.krystalbio.com, and
follow @KrystalBiotech on LinkedIn and Twitter.
CONTACT:
Investors and MediaMeg DodgeKrystal
Biotechmdodge@krystalbio.com
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2023 to Jul 2024